Published in Biomed Res Int on April 23, 2014
Thrombospondin-1 (TSP1) contributes to the development of vascular inflammation by regulating monocytic cell motility in mouse models of abdominal aortic aneurysm. Circ Res (2015) 0.95
Role of immune activation in progression to AIDS. Curr Opin HIV AIDS (2016) 0.92
Mononuclear cells and vascular repair in HHT. Front Genet (2015) 0.78
Zinc improves the immune function and the proliferation of lymphocytes in Cadmium-treated rats. Cent Eur J Immunol (2014) 0.77
The CXCL10/CXCR3 Axis and Cardiac Inflammation: Implications for Immunotherapy to Treat Infectious and Noninfectious Diseases of the Heart. J Immunol Res (2016) 0.77
Sitagliptin Reduces Inflammation and Chronic Immune Cell Activation in HIV+ Adults With Impaired Glucose Tolerance. J Clin Endocrinol Metab (2015) 0.76
Phosphodiesterase type 5 inhibitors: back and forward from cardiac indications. J Endocrinol Invest (2015) 0.76
Phosphodiesterase Type 5 Inhibitor Sildenafil Decreases the Proinflammatory Chemokine CXCL10 in Human Cardiomyocytes and in Subjects with Diabetic Cardiomyopathy. Inflammation (2016) 0.75
Gene expression profiling of rubella virus infected primary endothelial cells of fetal and adult origin. Virol J (2016) 0.75
The effects of storage temperature and duration of blood samples on DNA and RNA qualities. PLoS One (2017) 0.75
Mechanisms of angiogenesis and arteriogenesis. Nat Med (2000) 13.88
A new class of membrane-bound chemokine with a CX3C motif. Nature (1997) 7.87
Chemokine receptor specific for IP10 and mig: structure, function, and expression in activated T-lymphocytes. J Exp Med (1996) 6.36
9p21 DNA variants associated with coronary artery disease impair interferon-γ signalling response. Nature (2011) 6.25
Recombinant human interferon-inducible protein 10 is a chemoattractant for human monocytes and T lymphocytes and promotes T cell adhesion to endothelial cells. J Exp Med (1993) 4.94
IFN-gamma-inducible protein 10 (IP-10; CXCL10)-deficient mice reveal a role for IP-10 in effector T cell generation and trafficking. J Immunol (2002) 4.81
The functional role of the ELR motif in CXC chemokine-mediated angiogenesis. J Biol Chem (1995) 4.77
Inflammation in atherosclerosis. Arterioscler Thromb Vasc Biol (2012) 4.52
Biochemical characterization of a gamma interferon-inducible cytokine (IP-10). J Exp Med (1987) 4.21
Prevalence and associations of abdominal aortic aneurysm detected through screening. Aneurysm Detection and Management (ADAM) Veterans Affairs Cooperative Study Group. Ann Intern Med (1997) 3.08
An alternatively spliced variant of CXCR3 mediates the inhibition of endothelial cell growth induced by IP-10, Mig, and I-TAC, and acts as functional receptor for platelet factor 4. J Exp Med (2003) 2.91
The chemokine superfamily revisited. Immunity (2012) 2.83
The IP-10 chemokine binds to a specific cell surface heparan sulfate site shared with platelet factor 4 and inhibits endothelial cell proliferation. J Exp Med (1995) 2.68
Of mice and dogs: species-specific differences in the inflammatory response following myocardial infarction. Am J Pathol (2004) 2.61
Collateral circulation: past and present. Basic Res Cardiol (2008) 2.60
Differential expression of three T lymphocyte-activating CXC chemokines by human atheroma-associated cells. J Clin Invest (1999) 2.16
Role of inflammation in atherosclerosis. J Nucl Med (2007) 2.00
The CXCL10/CXCR3 axis mediates human lung mast cell migration to asthmatic airway smooth muscle. Am J Respir Crit Care Med (2005) 1.95
Chemokine CXCL10 promotes atherogenesis by modulating the local balance of effector and regulatory T cells. Circulation (2006) 1.95
Chemokines in vascular dysfunction and remodeling. Arterioscler Thromb Vasc Biol (2008) 1.94
The interferon-stimulated response element and a kappa B site mediate synergistic induction of murine IP-10 gene transcription by IFN-gamma and TNF-alpha. J Immunol (1995) 1.83
Lymphocyte-specific chemokine receptor CXCR3: regulation, chemokine binding and gene localization. Eur J Immunol (1998) 1.78
CXC chemokines: the regulatory link between inflammation and angiogenesis. Trends Immunol (2004) 1.77
Ultrastructure and molecular histology of rabbit hind-limb collateral artery growth (arteriogenesis). Virchows Arch (2000) 1.68
HIV entry inhibitor TAK-779 attenuates atherogenesis in low-density lipoprotein receptor-deficient mice. Arterioscler Thromb Vasc Biol (2005) 1.66
Role of C-X-C chemokines as regulators of angiogenesis in lung cancer. J Leukoc Biol (1995) 1.64
IP-10 blocks vascular endothelial growth factor-induced endothelial cell motility and tube formation via inhibition of calpain. Circ Res (2006) 1.61
Systemic chemokine levels, coronary heart disease, and ischemic stroke events: the PRIME study. Neurology (2011) 1.57
IP-10 inhibits epidermal growth factor-induced motility by decreasing epidermal growth factor receptor-mediated calpain activity. J Cell Biol (1999) 1.53
The 9p21 locus does not affect risk of coronary artery disease through induction of type 1 interferons. J Am Coll Cardiol (2013) 1.43
Interferon-gamma and the interferon-inducible chemokine CXCL10 protect against aneurysm formation and rupture. Circulation (2009) 1.40
Differential influence of chemokine receptors CCR2 and CXCR3 in development of atherosclerosis in vivo. Circulation (2005) 1.40
IP-10 induces dissociation of newly formed blood vessels. J Cell Sci (2009) 1.38
Inhibition of pulmonary fibrosis in mice by CXCL10 requires glycosaminoglycan binding and syndecan-4. J Clin Invest (2010) 1.38
The chemokine system in arteriogenesis and hind limb ischemia. J Vasc Surg (2007) 1.34
Shear stress-induced changes in atherosclerotic plaque composition are modulated by chemokines. J Clin Invest (2007) 1.33
Induction of the CXC chemokine interferon-gamma-inducible protein 10 regulates the reparative response following myocardial infarction. Circ Res (2009) 1.28
Chemokines in myocardial ischemia. Trends Cardiovasc Med (2005) 1.24
The pathophysiology of abdominal aortic aneurysm growth: corresponding and discordant inflammatory and proteolytic processes in abdominal aortic and popliteal artery aneurysms. J Vasc Surg (2010) 1.23
Differential expression of chemokines, risk of stable coronary heart disease, and correlation with established cardiovascular risk markers. Arterioscler Thromb Vasc Biol (2005) 1.23
Mechanisms of arteriogenesis. Acta Biochim Biophys Sin (Shanghai) (2008) 1.23
Chemokines and cardiovascular risk. Arterioscler Thromb Vasc Biol (2008) 1.22
Induction and suppression of interferon-inducible protein 10 in reperfused myocardial infarcts may regulate angiogenesis. FASEB J (2001) 1.21
Interferon-inducible protein-10 involves vascular smooth muscle cell migration, proliferation, and inflammatory response. J Biol Chem (1996) 1.21
Structure and function of the murine chemokine receptor CXCR3. Eur J Immunol (1999) 1.18
Cellular components and features of immune response in abdominal aortic aneurysms. Ann N Y Acad Sci (1996) 1.17
Transmural inflammation by interferon-gamma-producing T cells correlates with outward vascular remodeling and intimal expansion of ascending thoracic aortic aneurysms. FASEB J (2005) 1.17
CC chemokine ligand-5 (CCL5/RANTES) and CC chemokine ligand-18 (CCL18/PARC) are specific markers of refractory unstable angina pectoris and are transiently raised during severe ischemic symptoms. Circulation (2007) 1.17
Temporal patterns of gene expression after acute hindlimb ischemia in mice: insights into the genomic program for collateral vessel development. J Am Coll Cardiol (2004) 1.12
Identification and partial characterization of a variant of human CXCR3 generated by posttranscriptional exon skipping. J Immunol (2004) 1.12
CXCR3 antagonist NBI-74330 attenuates atherosclerotic plaque formation in LDL receptor-deficient mice. Arterioscler Thromb Vasc Biol (2007) 1.11
Shear stress, vascular remodeling and neointimal formation. J Biomech (2003) 1.10
CXCL10 can inhibit endothelial cell proliferation independently of CXCR3. PLoS One (2010) 1.10
Deletion of CCR2 but not CCR5 or CXCR3 inhibits aortic aneurysm formation. Surgery (2007) 1.08
Abnormal monocyte recruitment and collateral artery formation in monocyte chemoattractant protein-1 deficient mice. Vasc Med (2004) 1.08
The angiostatic activity of interferon-inducible protein-10/CXCL10 in human melanoma depends on binding to CXCR3 but not to glycosaminoglycan. Mol Ther (2004) 1.06
CXCL10: a candidate biomarker in transplantation. Clin Chim Acta (2012) 1.06
A functional IFN-gamma-inducible protein-10/CXCL10-specific receptor expressed by epithelial and endothelial cells that is neither CXCR3 nor glycosaminoglycan. J Immunol (2001) 1.06
Circulating chemokines accurately identify individuals with clinically significant atherosclerotic heart disease. Physiol Genomics (2007) 1.05
CXCR3, a double-edged sword in tumor progression and angiogenesis. Biochim Biophys Acta (2013) 1.05
Chemokines and incident coronary heart disease: results from the MONICA/KORA Augsburg case-cohort study, 1984-2002. Arterioscler Thromb Vasc Biol (2006) 1.04
Altered CXCR3 isoform expression regulates prostate cancer cell migration and invasion. Mol Cancer (2012) 1.03
Atherosclerosis in abdominal aortic aneurysms: a causal event or a process running in parallel? The Tromsø study. Arterioscler Thromb Vasc Biol (2010) 1.02
Bone marrow alterations and lower endothelial progenitor cell numbers in critical limb ischemia patients. PLoS One (2013) 0.98
Cell type and stimulus specific regulation of chemokine gene expression. Biochem Biophys Res Commun (1994) 0.98
Chemokines in cardiovascular risk prediction. Thromb Haemost (2007) 0.95
Effects of local MCP-1 protein therapy on the development of the collateral circulation and atherosclerosis in Watanabe hyperlipidemic rabbits. Cardiovasc Res (2003) 0.93
CXCR3 chemokine receptor-plasma IP10 interaction in patients with coronary artery disease. Circ J (2003) 0.92
Intraluminal abdominal aortic aneurysm thrombus is associated with disruption of wall integrity. J Vasc Surg (2012) 0.91
Local inflammation is associated with aortic thrombus formation in abdominal aortic aneurysms. Relationship to clinical risk factors. Thromb Haemost (2012) 0.89
Plasma chemokine levels are associated with the presence and extent of angiographic coronary collaterals in chronic ischemic heart disease. PLoS One (2011) 0.89
Systems-wide RNAi analysis of CASP8AP2/FLASH shows transcriptional deregulation of the replication-dependent histone genes and extensive effects on the transcriptome of colorectal cancer cells. Mol Cancer (2012) 0.89
CD40 ligand and MCP-1 as predictors of cardiovascular events in diabetic patients with stroke. J Atheroscler Thromb (2009) 0.86
Impairment in postischemic neovascularization in mice lacking the CXC chemokine receptor 3. Circ Res (2005) 0.86
Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med (2005) 0.85
Chemokines CCL3/MIP1α, CCL5/RANTES and CCL18/PARC are independent risk predictors of short-term mortality in patients with acute coronary syndromes. PLoS One (2012) 0.84
Interference of IP-10 expression inhibits vascular smooth muscle cell proliferation and intimal hyperplasia in carotid artery: a new insight in the prevention of restenosis. Cell Biochem Biophys (2012) 0.83
Differential expression of cytokines, chemokines and chemokine receptors in patients with coronary artery disease. Int J Cardiol (2008) 0.83
Circulating interferon-γ-inducible Cys-X-Cys chemokine receptor 3 ligands are elevated in humans with aortic aneurysms and Cys-X-Cys chemokine receptor 3 is necessary for aneurysm formation in mice. J Thorac Cardiovasc Surg (2011) 0.83
Trophoblast-induced changes in C-x-C motif chemokine 10 expression contribute to vascular smooth muscle cell dedifferentiation during spiral artery remodeling. Arterioscler Thromb Vasc Biol (2013) 0.82
An IP-10 (CXCL10)-derived peptide inhibits angiogenesis. PLoS One (2012) 0.81
The chemokine network in relation to infarct size and left ventricular remodeling following acute myocardial infarction. Am J Cardiol (2009) 0.81
Airway smooth muscle chemokine receptor expression and function in asthma. Clin Exp Allergy (2009) 0.80
Atherosclerotic Plaque Stability Is Affected by the Chemokine CXCL10 in Both Mice and Humans. Int J Inflam (2011) 0.79
Absence of chemokine (C-x-C motif) ligand 10 diminishes perfusion recovery after local arterial occlusion in mice. Arterioscler Thromb Vasc Biol (2014) 0.79
Serum interferon-gamma-inducible protein 10 level was increased in myocardial infarction patients, and negatively correlated with infarct size. Clin Biochem (2007) 0.78